Analyst IMS Investment Management Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.51M Buy
2,728
+187
+7% +$190K 0.08% 55
2025
Q4
$2.73M Buy
2,541
+1,080
+74% +$1.03M 0.08% 54
2025
Q3
$1.11M Sell
1,461
-229
-14% -$170K 0.03% 77
2025
Q2
$1.32M Sell
1,690
-1,296
-43% -$1.01M 0.05% 77
2025
Q1
$2.47M Buy
2,986
+1,228
+70% +$1.02M 0.1% 52
2024
Q4
$1.36M Sell
1,758
-916
-34% -$758K 0.05% 70
2024
Q3
$2.37M Buy
2,674
+1,085
+68% +$975K 0.09% 49
2024
Q2
$1.44M Buy
1,589
+1,142
+255% +$914K 0.06% 60
2024
Q1
$348K Buy
+447
New +$318K 0.02% 97

Other funds holding LLY

Analyst IMS Investment Management Services's LLY Position: Q1 2026 in Review

Analyst IMS Investment Management Services increased its Eli Lilly (LLY) stake by 7.4% in Q1 2026, buying an estimated $190K and bringing the position to 2,728 shares worth $2.51M. The position accounts for 0.08% of the portfolio, ranked #55.

Analyst IMS Investment Management Services first reported a position in LLY in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.73M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Analyst IMS Investment Management Services held 2,728 shares of Eli Lilly worth $2.51M as of Q1 2026.
  • Analyst IMS Investment Management Services bought 187 Eli Lilly shares in Q1 2026, an estimated $190K.
  • Eli Lilly made up 0.08% of Analyst IMS Investment Management Services's portfolio in Q1 2026, its #55 holding.
  • Analyst IMS Investment Management Services first reported a position in Eli Lilly in Q1 2024 and has held it in 9 quarters since.
  • Analyst IMS Investment Management Services's Eli Lilly position peaked at $2.73M in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Analyst IMS Investment Management Services's 13F filing for Q1 2026, filed 23 Apr 2026.